Biophysical Assessments of Acupuncture Points in Inflammatory Bowel Disease
NCT07681895
Digestive System Diseases, Gastroenteritis
View Trial DetailsNCT Number: NCT06750315
This study aimed to assess the clinical utility of the NLR (neutrophil lymphocyte ratio) and CRP Albumin ratio in predicting activity of IBD Patients in assiut university
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Assiut University, Asyut, Egypt
IBD definition term for two conditions (Crohn's disease and ulcerative colitis) is a chronic idiopathic inflammatory disease affecting the large intestine. It is characterized by relapsing mucosal inflammation. The aim of treatment is to induce and maintain disease remission. Assessing disease activity may help in optimizing the management of IBD patients.
The neutrophil-to-lymphocyte ratio (NLR) is a simple index that can be calculated from the results of ordinary blood tests; it is calculated from a blood sample by dividing the absolute neutrophil count by the absolute lymphocyte count . As the NLR can reflect the systemic status of inflammation or immune response.
The underlying mechanism that the NLR was a predictor of clinilcal relapse in UC patients with Mucosal healing remains poorly understood. Neutrophils induce cytotoxicity and inflammation in UC. A high NLR value may be due to high activity in UC and lowered mucosal barrier function, which may lead to the migration of neutrophils through the gut microbiota .
CRP is routinely used as a surrogate measure of intestinal inflammation and as a prognostic measure of nonresponse to medical therapy and colectomy in patients with IBD.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients more than 18 years newly diagnosed as IBD
-
Exclusion criteria
Time frame: 1 years
Neutrophil lymphocyte ratio and CRP/Albumin ratio in detecting activity in IBD Patients.
Contact information is provided by the study sponsor or research team.
Assiut University
Other
CRP/ Albumin Ratio and Neutrophil Lymphocyte Ratio in Predicting Activity in IBD Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07681895
Digestive System Diseases, Gastroenteritis
View Trial DetailsNCT07682038
Colitis, Colitis Ulcerative
View Trial DetailsNCT07676136
Abdominal Pain, Colonic Diseases
Stanford, California, United States
View Trial DetailsNCT07647640
Colitis, Colitis, Ulcerative
's-Hertogenbosch, Netherlands
View Trial Details